Skip to content

biomarkers

  • 3 min read

    BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine

    BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.

    Read more
  • 3 min read

    BC Platforms joins BRECISE to advance biomarkers research for precision oncology for prostate and bladder cancers

    We join BRECISE, a major cancer research initiative advancing biomarker development to improve diagnosis, treatment and personalized care across Europe.

    Read more